NCT06707259View on ClinicalTrials.gov

Clinical Study of Cord Blood-derived IL-10 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2027

Conditions
B-cell Non Hodgkin Lymphoma
Interventions
BIOLOGICAL

anti-CD19 IL10 CAR-NK

Lentiviral vector-transducted cord blood-derived NK cells to express anti-CD19-IL10 CAR

Trial Locations (1)

310009

RECRUITING

the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER